Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand

Sukit Yamwong (), Unchalee Permsuwan (), Sirana Tinmanee () and Piyamitr Sritara ()

Health Economics Review, 2014, vol. 4, issue 1, 1-7

Abstract: This health economic analysis provides cost effectiveness data for ticagrelor compared with both generic and branded clopidogrel in Thailand. Based on this analysis, it appears that ticagrelor is an economically valuable treatment for ACS compared with branded clopidogrel within the Thai context. Copyright Yamwong et al.; licensee Springer. 2014

Keywords: Cost-effectiveness; Ticagrelor; Acute coronary syndrome; Clopidogrel (search for similar items in EconPapers)
Date: 2014
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1186/s13561-014-0017-3 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-7:10.1186/s13561-014-0017-3

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/s13561-014-0017-3

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().